The pharmacological treatment of hyperglycemia in NIDDM

Diabetes Care

Volumn 19, Issue SUPPL. 1, 1996, Pages

  Zimmerman, B R ^a   Espenshade, J ^a   Fujimoto, W Y ^a   Santiago, J V ^a   Schade, D S ^a   Shamoon, H ^a   Simonson, D C ^a   Whitehouse, F W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; BIGUANIDE DERIVATIVE; INSULIN; SULFONYLUREA DERIVATIVE;

CONFERENCE PAPER; DIABETES CONTROL; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE;

EID: 0030022820     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (24)

1. Lebovitz HE: Oral antidiabetic agents: the emergence of alpha-glucosidase inhibitors Drugs 44 (Suppl. 3):21-28, 1992
2. Groop LC: Sulfonylureas in NIDDM Diabetes Care 15 737-754, 1992
3. Genuth S: Management of the adult onset diabetic with sulfonylurea drug failure. Endocrinol Metab Clin North Am 21:351-370, 1992
4. DCCT Research Group: The effect of intensive diabetes treatment on the development and progression of long term complication in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
5. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL: Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy JAMA 260:2864-2871, 1988
6. American Diabetes Association: Standards of medical care for patients with diabetes mellitus (Position Statement). Diabetes Care 18 (Suppl. 1) 8-15, 1995
7. Lindstrom T, Eriksson P, Olsson AG, Arnqvist HJ: Long-term improvement of glycemic control by insulin treatment in NIDDM patients with secondary failure. Diabetes Care 17:719-721, 1994
8. Yki-Jarvinen H, Kauppila M, Kujansuu E, Lahti J, Marjanen T, Niskanen L, Rajala S, Ryysy L, Salo S, Seppala P, et al : Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 327:1426-1433, 1992
9. United Kingdom Prospective Diabetes Study Group: United Kingdom Prospective Diabetes Study (UKPDS) 13: relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years Br Med J 310:83-88, 1995
10. Henry RR, Gumbiner B, Ditzler T, Wallace P, Lyon R, Glauber HS: Intensive conventional insulin therapy for type II diabetes: metabolic effects during a 6-month outpatient trial. Diabetes Care 16:21-31, 1993
11. Hepburn DA, MacLeod KM, Pell ACH, Scougal IJ, Frier BM: Frequency and symptoms of hypoglycemia experienced by patients with type 2 diabetes treated with insulin. Diabetic Med 10:231-237, 1993
12. Kudlacek S, Schernthaner G The effect of insulin treatment on HbAlc, body weight and lipids in type 2 diabetic patients with secondary failure to sulphonylureas: a five year follow up study. Horm Metab Res 24 478-483, 1992
13. Nathan DM, Roussell A, Godine J: Glyburide or insulin for metabolic control in non-insulin dependent diabetics: a randomized double-blind study. Ann Intern Med 108:334-339, 1988
14. The University Group Diabetic Program: Effects of hypoglycemic agents on vascular complication in patients with adult-onset diabetes. VII. Evaluation of insulin therapy final report Diabetes 31 (Suppl. 5): 1-26, 1982
15. Coniff RF, Shapiro JA, Seaton TB, Bray GA: Multicenter, placebo controlled trial comparing acarbose (BAYg 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus. Am J Med 98:443-445, 1995
16. Hermann LS, Bitzen PO, Kjellstrom T, Lindgarde F, Schersten B: Comparative efficacy of metformin and glibenclamide in patients with non-insulin-dependent diabetes mellitus. Diabete & Metab 17: 201-208, 1991
17. Haupt E, Knick B, Kschinsky T, Liebermeister H, Schneider J, Hirsch H. Oral antidiabetic combination therapy with sulphonylureas and metformin Diabete & Metab 17:224-231, 1991
18. Mitchell BD, Haffner SM, Hazuda HP, Valdez R, Stern MP: The relation between serum insulin levels and 8-year changes in lipid, lipoprotein, and blood pressure levels. Am J Epidemiol 136:12-22, 1992
19. Meechan WP, Darwin CH, Maalouf NB, Buchanan TA, Saad MF: Insulin and hypertension: are they related? Steroids 58: 621-624, 1993
20. DeFronzo RA, Goodman AM, The Multicenter Metformin Study Group. Efficacy of metformin in patients with non-insulin dependent diabetes mellitus. N Engl J Med 333 541-549, 1995
21. Strurnvoli M, Nierjhan N, Perriello G, et al. : Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med 333:050-554, 1995
22. Chiasson JL, Josse RG, Hunt JA, Palmason C, Rodger NW, Ross SA, Ryan EA, Tan MH, Wolever TM: The efficacy of acarbose in treatment of patients with non-insulin-dependent diabetes mellitus a multicenter controlled clinical trial Ann Intern Med 121 928-935, 1994
23. Gerich JE: Oral hypoglycemic agents. N Engl J Med 321:1231-1245, 1989
24. Hotta N, Kakuta H, Koh N, Sakakibara F, Haga T, Sano T, Okuyama M, Sakamoto N: The effects of acarbose on blood glucose profiles of type 2 diabetic patients receiving insulin therapy. Diabetic Med 10:355-358, 1993